Shares of Hims & Hers Health Inc. have roughly doubled over the past year — and Chief Executive Andrew Dudum cashed in on the ...

We recently published 10 Stocks That Vanished in Value Hims & Hers Health, Inc. (NYSE:HIMS) is one of the worst-performing stocks on Tuesday. Shares of telehealth company Hims & Hers Health dropped by ...

HIMS records subscriber surge and revenue growth in second-quarter 2025, but rising costs strain gross margins.

Morgan Stanley reports that third party data point to a 20% year-over-year decline for Hims & Hers app downloads in the month of July and that ...

In separate filings, Chief Legal Officer Soleil Boughton sold 2,572 shares at a price of $51.64 apiece for $132,818, while ...

Current health news highlights include UK investor backing in Assura's acquisition by PHP, Novo Nordisk's legal affairs over Wegovy drug sales, and Apollo Hospitals' increased AI investments. The CDC ...

The Voya Small Company Fund underperformed its benchmark, the Russell 2000 Index (the Index) on a net asset value basis. Read ...

The latest health news highlights UK investor moves as PHP secures a majority stake in Assura, Novo Nordisk's ongoing ...

In Q2 2025, Hims & Hers reported adjusted earnings of $0.17 per share, topping estimates of $0.15. Revenue rose 73% year-over ...

The Nasdaq and S&P 500 nabbed fresh record closes, while the Dow added more than 480 points as interest rate hopes soared ...

May 31, 2021. China's vast manufacturing sector grew at the fastest pace in eight months in May, blowing past e ...

European shares hit a near two-week high on Wednesday, but weak earnings and a costly trade deal with the U.S. has some investors worried about any future gains. Benedicte Lowe from BNP Paribas told ...